Product
ST101
Name
ST101
1 clinical trial
8 indications
Indication
GlioblastomaIndication
melanomaIndication
Breast CancerIndication
Prostate CancerIndication
Glioblastoma MultiformeIndication
Brain CancerIndication
Metastatic MelanomaIndication
MelanomaClinical trial
A Phase 1-2 Dose-escalation and Expansion Study of ST101 in Patients With Advanced Unresectable and Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-01